Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care
Current biopharmaceutical manufacturing systems are not compatible with portable or distributed production of biologics, as they typically require the development of single biologic-producing cell lines followed by their cultivation at very large scales. Therefore, it remains challenging to treat pa...
| Main Authors: | , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
Nature Publishing Group
2017
|
| Online Access: | http://hdl.handle.net/1721.1/109076 https://orcid.org/0000-0003-4513-8575 https://orcid.org/0000-0002-5253-3365 https://orcid.org/0000-0002-2031-8871 https://orcid.org/0000-0003-0420-2235 https://orcid.org/0000-0002-9999-6690 |